To further protect drug safety for the people, on March 6, 2020, NMPA issued an Announcement with decisions made to revise the [adverse reactions], [precautions] and other Entries on the package inserts of triamcinolone acetonide injections (including Triamcinolone Acetonide Acetate Injection, Triamcinolone Acetonide Injection).